IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Turkish Journal of Clinics and Laboratory
  • Volume:14 Issue:2
  • Assessment Of Serum Cyanocobalamin Level And Importance In Patients With Hematological Malignancies

Assessment Of Serum Cyanocobalamin Level And Importance In Patients With Hematological Malignancies

Authors : Esra ZEYNELGİL, Özlem DOĞAN, Buğra SAĞLAM, Mehmet ASIL
Pages : 270-273
Doi:10.18663/tjcl.1225685
View : 26 | Download : 21
Publication Date : 2023-06-30
Article Type : Research Paper
Abstract :ABSTRACT Aim: In our study, we planned to investigate the effect of serum cyanocobalamin insert ignore into journalissuearticles values(Vitamin B12); levels at the time of diagnosis in patients with various hematological malignancies. Patients and Methods: Two hundred and one patients between 18-75 years old diagnosed with various hematological malignancies and 30 healthy controls applying to outpatient and inpatient clinics of Hematology Department in Necmettin Erbakan University Meram Faculty of Medicine between 2010-2014 years were included in the study. Demographic and clinical data and laboratory findings of the patients included in the study were recorded retrospectively. Results: A total of 231 patients, 132 men insert ignore into journalissuearticles values(57.1%); and 99 women insert ignore into journalissuearticles values(42.9%);, were included in our study, of which 201 were patients and 30 were healthy controls. The mean serum vitamin B12 concentration of all patients was found as 344.9 ± 279.0 pg/mL. When vitamin B12 levels were analyzed according to diagnostic groups, it was found to be highest in CML insert ignore into journalissuearticles values(596.0 ± 428.3 pg / mL); and ALL insert ignore into journalissuearticles values(524.5 ± 442.6 pg / mL); patients and lowest in AML patients insert ignore into journalissuearticles values(240.9 ± 178, 0 pg / mL);; the difference was statistically significant insert ignore into journalissuearticles values(p <0.001);. Vitamin B12 levels of diagnostic groups were found to have no significant effect on survival. Conclusion: Cyanocobalamin levels were found to be high in patients with hematological malignancies, especially in CML patients. A high level of cyanocobalamin may be helpful in prediction of CML, however prospective studies are required to support this finding.
Keywords : cyanocobalamin, CML, ALL, AML, Vitamin B12

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025